Emerging research suggests that glymphatic system impairment plays a central role in neurodegenerative diseases such as Alzheimer’s and Parkinson’s, by reduced clearance of toxic proteins like Aβ, tau and α-synuclein from the brain (Sun et al., 2025). The gene discussed is MAPT; the disease is neurodegenerative disease.